Debbie Liao

机构：Boundless Bio (United States) · ORCID：0009-0006-0019-0133

发表论文 70 篇 · 总被引 7898 次 · h-index 16

代表论文

• Tumor-Associated Macrophages Regulate Murine Breast Cancer Stem Cells Through a Novel Paracrine EGFR/Stat3/Sox-2 Signaling Pathway (2012 · Stem Cells · 被引 308)
• Endothelial Cell HIF-1α and HIF-2α Differentially Regulate Metastatic Success (2012 · Cancer Cell · 被引 170)
• EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor (2016 · Cancer Research · 被引 122)
• Discovery of BMS-986365, a First-in-Class Dual Androgen Receptor Ligand-Directed Degrader and Antagonist, for the Treatment of Advanced Prostate Cancer (2025 · Clinical Cancer Research · 被引 16)
• Abstract 1733: EGF816, a novel covalent inhibitor of mutant-selective epidermal growth factor receptor, overcomes T790M-mediated resistance in NSCLC (2014 · Cancer Research · 被引 10)
• Abstract 1626: Tumors driven by oncogene amplified extrachromosomal DNA (ecDNA) demonstrate enhanced sensitivity to cell cycle checkpoint kinase 1 (CHK1) inhibition (2023 · Cancer Research · 被引 5)